Neogen Chemicals Ltd Stock Price Today (NSE: NEOGEN)

Neogen Chemicals Ltd

2056.10+68.00 (+3.42%)
Market Closed

Fundamental Score

...

Neogen Chemicals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Neogen Chemicals Ltd share price today is 2056.10, up +3.42% on NSE/BSE as of 3 August 2026. Neogen Chemicals Ltd (NEOGEN) is a Mid-cap company in the Specialty Chemicals sector with a market capitalisation of 6.22K (Cr). The 52-week high for NEOGEN share price is 2374.00 and the 52-week low is 966.70. At a P/E ratio of 216.25x, NEOGEN is currently trading above its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 3.58% and a debt-to-equity ratio of 1.71.

Neogen Chemicals Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
2374.00
Low
1920.00
Volume
1.4L
Change
+0.47%

Neogen Chemicals Ltd share price chart: 0.47% return over the past month. 52-week high ₹2374.00, 52-week low ₹966.70.

Neogen Chemicals Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
2026.002075.002000.602023.101.75L (Cr)
2032.702045.101965.001988.1096.85K (Cr)
2039.902079.902003.702048.301.28L (Cr)
2105.802220.002011.002024.307.03L (Cr)
2135.002159.702042.302064.101.49L (Cr)
2080.002121.902025.002062.8054.02K (Cr)
2190.002255.002146.302155.3081.26K (Cr)
2157.502241.902122.102182.601.25L (Cr)
2321.402334.902149.002175.601.85L (Cr)
2270.002374.002252.602321.402.72L (Cr)

Neogen Chemicals Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
2030.002374.001920.002023.10-0.34%
1880.002090.001752.002024.90+7.71%
1650.001887.001547.001858.10+12.61%
1124.101720.001124.101637.50+45.67%
1360.001501.001101.201112.00-18.24%
1243.501488.901180.001464.30+17.76%
1184.201346.401090.501216.50+2.73%
1127.601199.00966.701184.20+5.02%
1442.601485.801118.901125.30-22.00%
1500.001557.201435.801442.60-3.83%
1426.001607.681425.001500.50+5.22%
1539.801539.801390.001404.20-8.81%

AI Research Briefing

Powered by Gemini · 2026-04-10

Overvalued small-cap specialty chemical company with stretched financials and high execution risk.

Research Confidence
5.0/10Moderate
MICRO-CAP DARK HORSEBreakdown (1M: -21.61%, 3M: -22.45%, 6M: -32.73%)Expensive (90.84x P/E vs. industry P/E of 29.2x)

WHAT'S HAPPENING NOW (last 2-4 weeks)

Neogen Chemicals' stock surged 7.12% on April 8, 2026, outperforming the Sensex and the Chemicals sector. The company held an EGM on March 29, 2026, regarding a preferential issue. On March 7, 2026, the board approved a preferential issue of to Cadamba Solutions Private Limited, a promoter group entity, at

CORE STORY (THE REAL GAME)

Neogen is a small-cap specialty chemical play whose narrative hinges on capitalizing on the China+1 strategy and rising domestic demand. The market is likely pricing in continued growth in specialty chemicals, driven by government initiatives and increasing industrialization.

Why Now
  • ₹161 crore preferential issue
  • Q3 revenue growth of 9.23%
  • ₹60 crore insurance payment
Potential Catalysts
  • New order wins in specialty chemicals
  • Significant margin expansion
  • Decline in raw material prices
Key Risks
  • Rich valuation (90.84x P/E)
  • Negative free cash flow
  • High Debt/Equity (1.41)
Institutional Activity

FII decreased stake by 2.2%, while DII increased by 2.26%.

Macro Context

India's chemical production is projected to increase by 10.9% in 2026.

Cash Flow Quality

No (₹-703.28 Cr FCF 5Y)

3–6 Month Outlook

Neogen's future hinges on maintaining high growth in the specialty chemicals segment. Failure to improve profitability and manage debt will lead to significant downside.

Primary Thesis Risk

Inability to justify high valuation due to poor profitability and stretched financials.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

3.58%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

6.46%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

16.61%

Average operating profit margin over 5 years

Dividend Yield

0.04%

Annual dividend as % of current share price

Neogen Chemicals Ltd Valuation Check

Poor

Price to Earnings (P/E)

216.25x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.95x

Average P/E of all peers in this sector

Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Shareholding Pattern

Excellent

Promoter Holding

53.01%

% shares held by company founders/management

Poor

FII Holding

4.29%

% shares held by foreign institutional investors

Excellent

DII Holding

21.67%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

23.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

23.67%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

21.57%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

20.70%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-4.09%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-1.70%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.71x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.55x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-1.30K (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Neogen Chemicals Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of NEOGEN across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Strong Operating Margins (16.61%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Robust Profit Growth (23.67%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (21.57%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (20.70% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Balanced Promoter Holding (53.01%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Strong Institutional Confidence (FII+DII: 25.96%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Risk Factors

9 factors identified

Below-Average Return on Equity (3.58%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.46%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 216.25x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Weak Earnings Growth (-4.09% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-1.70% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Elevated Debt Levels (D/E: 1.71)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (1.55x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-1299.01 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

High Share Pledging Risk (23.00%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

Neogen Chemicals Ltd vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Neogen Chemicals Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
18.9/100
2056
₹6217.32
216.3
Average
3.58%
Poor
6.46%
Poor
1.7
Average
-1.70%
Poor
20.70%
Excellent
0.04%
65.3/100
1611
₹159989.82
65.0
Average
23.92%
Excellent
31.02%
Excellent
0.0
Excellent
16.69%
Excellent
14.89%
Good
0.73%
42.9/100
4367
₹45440.05
77.3
Average
7.78%
Poor
9.86%
Poor
0.3
Excellent
36.34%
Excellent
13.52%
Good
0.07%
62.7/100
7568
₹39027.62
58.4
Average
20.26%
Excellent
21.37%
Excellent
0.3
Excellent
22.16%
Excellent
22.95%
Excellent
0.20%
32.8/100
1662
₹23159.08
41.4
Average
9.97%
Poor
11.49%
Average
0.3
Excellent
-6.33%
Poor
12.59%
Good
0.44%
36.3/100
1540
₹19624.13
86.7
Average
9.66%
Poor
11.92%
Average
0.2
Excellent
0.00%
38.7/100
489
₹18171.13
44.1
Average
7.13%
Poor
6.85%
Poor
0.8
Good
-4.67%
Poor
12.96%
Good
0.20%
Atul Ltd...
ATUL500027
58.2/100
6737
₹18051.49
26.6
Average
11.49%
Average
14.90%
Average
0.0
Excellent
1.26%
Average
10.95%
Good
0.49%
52.2/100
3634
₹16002.35
38.4
Average
10.92%
Average
14.68%
Average
0.0
Excellent
7.67%
Good
9.41%
Good
0.68%
62.09999999999999/100
4817
₹15713.17
38.1
Average
16.61%
Good
21.47%
Excellent
0.0
Excellent
27.91%
Excellent
15.86%
Excellent
0.21%
33.3/100
1208
₹14449.70
84.9
Average
5.50%
Poor
7.36%
Poor
0.6
Good
19.29%
Excellent
23.88%
Excellent
0.06%

Neogen Chemicals Ltd PE Ratio History

Historical price-to-earnings ratio for NEOGEN — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202513.20₹1184.2089.7x
FY 202413.96₹2231.15159.8x
FY 202320.03₹1480.0573.9x
FY 202218.70₹1250.6566.9x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Neogen Chemicals Ltd Dividend History

Annual cash dividends paid by NEOGEN — dividend yield 0.04%

Financial YearDividends Paid (₹ Cr)
FY 20255.28 Cr
FY 20247.48 Cr
FY 20236.86 Cr
FY 20225.25 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Neogen Chemicals Ltd Quarterly Performance

Latest quarterly metrics for NEOGEN — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

21.57%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

23.67%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

20.70%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-1.70%

Compounded annual net profit growth over 5 years

Neogen Chemicals Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for NEOGEN — calculated from daily price history

50RSI 14
Neutral — RSI 50

Momentum is balanced — neither overbought nor oversold.

SMA 50
1972
▲ Price above SMA 50 — Short-term bullish
SMA 200
1496
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
141K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Neogen Chemicals Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Neogen Chemicals Ltd (NEOGEN) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Neogen Chemicals Ltd

About NEOGEN (Neogen Chemicals Ltd)

Neogen Chemicals Ltd is a prominent Indian manufacturer specializing in specialty chemicals, catering to a diverse range of industries. The company distinguishes itself through its... strong focus on producing niche chemical compounds that are essential building blocks for various applications. These specialized chemical products serve as key ingredients in the manufacturing of pharmaceuticals, agrochemicals, flavors, fragrances, polymers, and electronic chemicals. Neogen’s robust research and development capabilities enable them to create innovative solutions tailored to the specific needs of their clients, thereby establishing the company as a reliable and dependable supplier in the specialty chemical market. Neogen's commitment to product development ensures a steady stream of new and improved products. Neogen Chemicals Ltd excels in the production of a wide array of specialty organic chemicals that include bromine and chlorine compounds. Their bromine compounds consist of alkyl bromides, dibromoalkanes, and other derivatives essential for creating a variety of products. Their chlorine compounds consist of derivatives and other compounds. They are known for their precision in creating various compounds catering to specialized processes. Neogen's products are critical components in numerous applications. By specializing in these complex chemical families, Neogen ensures it meets stringent quality and purity demands, making them an attractive choice for companies that require high-performance chemicals. Neogen Chemicals Ltd has built a reputation for quality, reliability, and innovation. Its strategic focus on niche markets, combined with its strong manufacturing and research capabilities, has allowed Neogen to establish a prominent position in the specialty chemicals sector. The company is committed to sustainability and adheres to rigorous environmental standards in its production processes. Neogen continually invests in expanding its production capacity and enhancing its technological capabilities to meet growing market demand. The company's unwavering commitment to excellence positions them as a key player in the chemical industry, poised for continued growth and success.

Company Details

Symbol:NEOGEN
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Dr. Harin Haridas Kanani Ph.D.
MD & Executive Director
Mr. Shyamsunder Radeshyam Upadhyay
Director of Operations & Whole Time Director
Mr. Gopikrishnan Sarathy
Chief Financial Officer

NEOGEN Share Price: Frequently Asked Questions

What is the current share price of Neogen Chemicals Ltd?

Neogen Chemicals Ltd (NEOGEN) trades at ₹2056.10 on NSE and BSE. Market cap ₹6.22K (Cr). Educational data only.

What is the P/E ratio of Neogen Chemicals Ltd?

Neogen Chemicals Ltd has a P/E of 216.25x vs industry average 31.95x.

What is the Bull Run score for Neogen Chemicals Ltd?

Neogen Chemicals Ltd has a Bull Run score of 18.9/100 based on 25+ financial parameters.

Does Neogen Chemicals Ltd pay dividends?

Neogen Chemicals Ltd has a dividend yield of 0.04%. Past dividends don't guarantee future payments.

What is the ROE of Neogen Chemicals Ltd?

Neogen Chemicals Ltd has ROE of 3.58%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Neogen Chemicals Ltd?

Neogen Chemicals Ltd has debt-to-equity of 1.71.

Is Neogen Chemicals Ltd a good investment?

Bull Run gives Neogen Chemicals Ltd a score of 18.9/100. This is not investment advice — consult a SEBI-registered advisor.